logo

ITI Pharma and Healthcare Fund - Regular Plan - Growth Option

Category: Equity: Sectoral-Pharma and Healthcare Launch Date: 08-11-2021
AUM:

₹ 161.86 Cr

Expense Ratio

2.34%

Benchmark

NIFTY Healthcare TRI

ISIN

INF00XX01BL5

Minimum Investment

5000.0

Minimum Topup

1000.0

Minimum SIP Amount

500

Fund Manager

Dhimant Shah, Rohan Korde, Tanay Gabhawala

Fund Performance 1Y (%) 3Y (%) 5Y (%)
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 44.64 - -
NIFTY Healthcare TRI 49.8 13.64 20.09
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%

Overview

NAV
13.4729
Last change
0.02 (0.17%)
Fund Size (AUM)
₹ 161.86 Cr
Performance
12.58% (Inception)

Asset Allocation

Equity

Debt

Others

Nav Movement

Investment Objective

The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.

Fund Manager
Dhimant Shah, Rohan Korde, Tanay Gabhawala
Riskometer
Very High

Top 10 Holdings

Company Holdings (%)
Sun Pharmaceutical Industries Ltd. 15.81
Max Healthcare Institute Ltd. 6.15
Lupin Ltd. 6.05
Dr. Reddy's Laboratories Ltd. 5.37
Mankind Pharma Ltd. 5.06
Apollo Hospitals Enterprise Ltd. 4.75
Suven Pharmaceuticals Ltd. 4.41
Divi's Laboratories Ltd. 4.14
Zydus Lifesciences Ltd. 3.62
Laurus Labs Ltd. 2.93

Sector Allocation

Sector Holdings (%)
Healthcare 95.42
Chemicals 4.25
Others 0.33